Boc-4-APAc-OH

Online Inquiry

CAT#CP26060
CAS81196-09-0
Synonyms/Alias81196-09-0;2-(4-((tert-Butoxycarbonyl)amino)phenyl)aceticacid;{4-[(tert-butoxycarbonyl)amino]phenyl}aceticacid;4-(T-BUTYLOXYCARBONYLAMINO)PHENYLACETICACID;Boc-4-aminophenylaceticacid;SBB052668;2-(4-{[(tert-butoxy)carbonyl]amino}phenyl)aceticacid;2-{4-[(tert-butoxy)carbonylamino]phenyl}aceticacid;2-{4-[(tert-butoxycarbonyl)amino]phenyl}aceticacid;AC1ME8FM;AC1Q1NA6;Oprea1_154233;SCHEMBL977842;N-Boc-4-aminophenylaceticacid;4-(Boc-amino)phenylaceticAcid;CTK7G5515;MolPort-003-700-193;ZXYKUPPWJMOKGE-UHFFFAOYSA-N;ZINC173232;2-[4-[(2-methylpropan-2-yl)oxycarbonylamino]phenyl]aceticAcid;ANW-47778;AKOS000169793;MCULE-2911942723;4-t-butoxycarbonylaminophenylaceticacid;AJ-17585
Chemical Name4-(t-Butyloxycarbonylamino)-phenylacetic acid
M.F/FormulaC13H17NO4
M.W/Mr.251,28 g/mole
Quick Inquiry
×
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Customer Support & Price Inquiry

* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).

Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!

 ICI 174,864 is an opioid peptide, belonging to subclasses of opioid receptors. Its chemical structure is N, N-di ...

 Carnosine (β-alanyl-l-histidine), containing an imidazole moiety, is an intramuscular dipeptide consisting of β ...

 Developed by the German company Hoechst Marion Roussel and derived from genetic modification of hirudin, lepirud ...

  Etomidate, a highly selective intravenous anesthetic agent, was first synthesized at Janssen Pharmaceuticals in ...

What is abaloparatide? Abaloparatide (formerly known as BA058) is an investigational analog of human PTHrP (1-34) being devel ...

Contact Us

USA

Address:

Tel: |

Email:

Germany

Address:

Copyright © 2024 Creative Peptides. All rights reserved.